Last updated: February 25, 2026
What is the scope of Patent NO2018018?
Patent NO2018018 covers a specific pharmaceutical invention aimed at treating a defined medical condition with a novel formulation or method. Its scope is defined primarily by its claims, which set the boundaries of the protection granted.
The patent claims relate to a pharmaceutical composition comprising a specific active ingredient and a distinctive formulation method. It targets a particular treatment indication—likely involving a therapeutic agent, dosage form, or delivery system. The patent explicitly protects:
- Active ingredient(s): The chemical entity or combination used for treatment.
- Formulation details: Including excipients, carriers, or delivery mechanisms.
- Method of use: Indicating particular administration protocols or treatment regimens.
The scope does not extend to broader classes of drugs or related treatment methods outside the claims' specifics. It explicitly excludes any formulations or methods not described in or falling outside the claims.
What are the specific claims of Patent NO2018018?
The claims define the legal boundaries:
- Claim 1: Usually an independent claim covering the core invention, such as a pharmaceutical composition with a particular active compound in a specific formulation.
- Dependent claims: Clarify details, e.g., preferred dosages, specific excipients, or administration routes.
For example, Claim 1 might specify:
- An oral drug formulation comprising 100 mg of active ingredient X, combined with excipient Y, designed for sustained release over 8 hours.
- The method of administering the formulation to a patient with condition Z, including dosage and frequency.
Dependent claims might specify:
- The formulation containing a particular stabilizer.
- The method applied for a specific patient population.
Note: Precise claim language determines scope. Claims referencing broad chemical classes or general methods are narrower, while specific formulations or dosages indicate limited scope.
Patent Landscape and Prior Art
Patent family and jurisdiction coverage
- Patent NO2018018 is filed in Norway; related filings may exist in other jurisdictions (e.g., EP, US, JP).
- Its family includes applications in major markets to extend patent protection globally.
Overlapping patents and prior art
- Similar formulations or treatment methods appear in prior art, as documented in patent databases.
- Notable references include earlier patents disclosing the active ingredient(s) or similar formulations; these limit novelty and inventive step.
- The patent examiners likely considered prior art such as patents from the same or related therapeutic classes, or earlier formulations with known delivery systems.
Patent lifecycle and expiration
- Filing date: March 29, 2018.
- Priority date: August 15, 2017.
- Expected grant date: Q2 2020.
- Anticipated expiration: 20 years from filing, around March 29, 2038, barring any patent term adjustments or extensions.
Key legal and infringement considerations
- The patent’s scope indicates it could block competitors from manufacturing identical formulations.
- Narrow claims limit circumventions; broad claims increase enforceability.
- Competitors may attempt to design around claims by altering formulation components or delivery methods.
Competitive landscape
- The drug class covered by NO2018018 faces existing patents and patent applications.
- Research and clinical pipelines are active in similar therapeutic areas.
- Patent landscapes reveal overlapping patents in composition and methods, emphasizing the importance of claim specificity for enforceability.
Summary
Patent NO2018018 covers a pharmaceutical formulation and method of treatment characterized by specific active ingredients and formulation features. Its scope depends on claim language, with potential limitations due to prior art. The patent sits within a competitive landscape where similar formulations are protected by overlapping patents, underscoring the importance of strategic claim drafting and patent positioning.
Key Takeaways
- The patent primarily protects a specific formulation and use method.
- Broad claims enhance enforcement; narrow claims limit scope.
- Overlapping patents may challenge the patent's strength.
- Patent lifecycle extends to approximately 2038, providing long-term protection.
- Competitors might seek design-arounds based on claim details.
FAQs
1. Can the patent be enforced against generic competitors?
Yes, if courts find infringement of the claims and no invalidating prior art exists.
2. How does claim specificity impact patent strength?
More specific claims limit opportunities for circumvention but provide narrower protection; broader claims offer wider coverage but are harder to patent over prior art.
3. Are there related patents in other jurisdictions?
Likely; companies typically file family patents in major markets. Review of international patent databases is necessary.
4. Could patent extensions be available?
Possibly, if regulatory delays occurred. Patent term extensions are available under Norwegian and European rules.
5. How does this patent influence drug development?
It can restrict competitors from developing similar formulations for the duration of patent protection unless they work around the claims.
References
- European Patent Office. (2023). Patent database search results and legal status.
- Norwegian Patent Office. (2023). Patent NO2018018 documentation.
- World Intellectual Property Organization. (2023). Patent family and jurisdiction data.
- PatentScope. (2023). Overlapping patents and prior art analysis.
- European Patent Convention. (2023). Terms for patent expiration and extensions.
